JP5239023B2 - コイヘルペスウイルス(khv)病用dnaワクチン - Google Patents
コイヘルペスウイルス(khv)病用dnaワクチン Download PDFInfo
- Publication number
- JP5239023B2 JP5239023B2 JP2008510736A JP2008510736A JP5239023B2 JP 5239023 B2 JP5239023 B2 JP 5239023B2 JP 2008510736 A JP2008510736 A JP 2008510736A JP 2008510736 A JP2008510736 A JP 2008510736A JP 5239023 B2 JP5239023 B2 JP 5239023B2
- Authority
- JP
- Japan
- Prior art keywords
- dna
- protein
- khv
- carp
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
Claims (5)
- コイヘルペスウイルス(KHV)のタンパク質をコードするDNAを含むコイ用DNAワクチンであって、前記タンパク質が以下の(a)〜(d)のいずれかであるワクチン。
(a)配列番号2、4、6、8、又は10に示されるアミノ酸配列からなるKHVのタンパク質;
(b) 配列番号12、14、16、18、又は20に示されるアミノ酸配列からなるKHVのタンパク質;
(c)配列番号2、4、6、8、又は10に示されるアミノ酸配列において、1〜20個のアミノ酸が欠失、置換若しくは付加されたアミノ酸配列からなり、かつKHVに対する免疫原性を有するタンパク質;
(d)配列番号12、14、16、18、又は20に示されるアミノ酸配列において、1〜20個のアミノ酸が欠失、置換若しくは付加されたアミノ酸配列からなり、かつKHVに対する免疫原性を有するタンパク質; - DNAが、以下の(e)〜(h)のいずれかである請求項1記載のワクチン。
(e)配列番号1、3、5、7、又は9に示される塩基配列、又はその相補的配列からなるDNA;
(f)配列番号11、13、15、17、又は19に示される塩基配列、又はその相補的配列からなるDNA;
(g)配列番号1、3、5、7、又は9に示される塩基配列において、1〜20個の塩基が欠失、置換若しくは付加された塩基配列からなり、かつKHVに対する免疫原性を有するタンパク質をコードするDNA、又はその相補的配列からなるDNA;
(h)配列番号11、13、15、17、又は19に示される塩基配列において、1〜20個の塩基が欠失、置換若しくは付加された塩基配列からなり、かつKHVに対する免疫原性を有するタンパク質をコードするDNA、又はその相補的配列からなるDNA; - DNAが、発現ベクターに組み込まれていることを特徴とする請求項1又は2記載のワクチン。
- 請求項1〜3のいずれかに記載のコイ用DNAワクチンをコイに投与することを特徴とする、コイヘルペスウイルス(KHV)病の予防又は治療方法。
- 請求項1〜3のいずれかに記載のコイ用DNAワクチンの、コイのコイヘルペスウイルス(KHV)病に対する免疫応答の誘発への使用方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008510736A JP5239023B2 (ja) | 2006-04-13 | 2007-01-30 | コイヘルペスウイルス(khv)病用dnaワクチン |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006111414 | 2006-04-13 | ||
JP2006111414 | 2006-04-13 | ||
JP2008510736A JP5239023B2 (ja) | 2006-04-13 | 2007-01-30 | コイヘルペスウイルス(khv)病用dnaワクチン |
PCT/JP2007/051498 WO2007119279A1 (ja) | 2006-04-13 | 2007-01-30 | コイヘルペスウイルス(khv)病用dnaワクチン |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2007119279A1 JPWO2007119279A1 (ja) | 2009-08-27 |
JP5239023B2 true JP5239023B2 (ja) | 2013-07-17 |
Family
ID=38609100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008510736A Active JP5239023B2 (ja) | 2006-04-13 | 2007-01-30 | コイヘルペスウイルス(khv)病用dnaワクチン |
Country Status (7)
Country | Link |
---|---|
US (1) | US8052977B2 (ja) |
EP (1) | EP2011876B1 (ja) |
JP (1) | JP5239023B2 (ja) |
CN (1) | CN101495636B (ja) |
IL (1) | IL194474A0 (ja) |
TW (1) | TW200842189A (ja) |
WO (1) | WO2007119279A1 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010109874A1 (ja) | 2009-03-26 | 2010-09-30 | 国立大学法人東京海洋大学 | コイヘルペスウイルス特異的抗体及びその抗原 |
EP2560985B1 (en) | 2010-04-21 | 2016-06-29 | Pharmaq AS | Nucleic acid sequences of a fish virus and the use thereof |
EP2487241A1 (en) | 2011-02-09 | 2012-08-15 | Westfälische Wilhelms-Universität Münster | RNAi agents and compositions useful as carp therapeutics |
CN104159609B (zh) * | 2011-12-30 | 2018-05-22 | 格斯瓦尔股份公司 | 用于预防锦鲤疱疹病毒(khv)引起的疾病的重组khv和疫苗 |
EP2893937B1 (en) * | 2012-09-10 | 2020-07-01 | National University Corporation Tokyo University of Marine Science And Technology | Dna vaccine against pseudotuberculosis in marine fish |
CN102988973A (zh) * | 2012-10-29 | 2013-03-27 | 吉林农业大学 | 一种锦鲤疱疹病毒核酸疫苗 |
CN102973951A (zh) * | 2012-11-26 | 2013-03-20 | 吉林农业大学 | 一种锦鲤疱疹病毒orf25核酸疫苗 |
EP2950816B1 (en) | 2013-02-04 | 2019-07-31 | Schweitzer Biotech Company Ltd. | The use of dna sequences encoding an interferon as vaccine adjuvants |
GB2551984B (en) | 2016-06-30 | 2019-01-16 | Pharmaq As | Fish virus |
CN111635961B (zh) * | 2020-06-30 | 2024-05-10 | 广东省农业科学院动物卫生研究所 | 锦鲤疱疹病毒检测试剂盒和检测方法 |
CN114306574B (zh) * | 2021-12-30 | 2023-10-17 | 北京市水产科学研究所(国家淡水渔业工程技术研究中心) | 一种抵抗病原菌感染锦鲤蛋白及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3950500B2 (ja) | 1995-09-23 | 2007-08-01 | 独立行政法人水産総合研究センター | 魚類用のイリドウイルス感染症ワクチンと診断剤並びにこれ等の製法 |
US5780448A (en) | 1995-11-07 | 1998-07-14 | Ottawa Civic Hospital Loeb Research | DNA-based vaccination of fish |
JP2002125674A (ja) | 2000-10-19 | 2002-05-08 | Hokkaido | 伝染性造血器壊死症(ihn)ウイルスに対する遺伝子読み枠ワクチン、その製法及び投与法 |
JP4863341B2 (ja) | 2001-09-06 | 2012-01-25 | Meiji Seikaファルマ株式会社 | ヒラメラブドウイルス感染魚類用dnaワクチン |
IL153775A0 (en) * | 2003-01-01 | 2003-07-31 | Yissum Res Dev Co | Immunizing fish against viral infection |
JP4704671B2 (ja) | 2003-10-02 | 2011-06-15 | 明治製菓株式会社 | ヒラメのウイルス性出血性敗血症に対するdnaワクチン |
-
2007
- 2007-01-30 CN CN2007800128639A patent/CN101495636B/zh not_active Expired - Fee Related
- 2007-01-30 EP EP07707716.2A patent/EP2011876B1/en not_active Not-in-force
- 2007-01-30 US US12/296,459 patent/US8052977B2/en not_active Expired - Fee Related
- 2007-01-30 WO PCT/JP2007/051498 patent/WO2007119279A1/ja active Application Filing
- 2007-01-30 JP JP2008510736A patent/JP5239023B2/ja active Active
- 2007-04-24 TW TW096114531A patent/TW200842189A/zh unknown
-
2008
- 2008-10-02 IL IL194474A patent/IL194474A0/en unknown
Non-Patent Citations (4)
Title |
---|
JPN6011069579; Kurita J. et al.: 'Accession No. Q75N32, Definition: Hypothetical protein.' Database DDBJ/EMBL/GenBank [online] , 20040705 * |
JPN6011069580; Kurita J. et al.: 'Accession No. Q75N31, Definition: Membrane protein.' Database DDBJ/EMBL/GenBank [online] , 20040705 * |
JPN6011069581; Kurita J. et al.: 'Accession No. Q75N28, Definition: Hypothetical protein.' Database DDBJ/EMBL/GenBank [online] , 20050201 * |
JPN6011069582; Kurita J. et al.: 'Accession No. Q75N51, Definition: Membrane protein.' Database DDBJ/EMBL/GenBank [online] , 20040705 * |
Also Published As
Publication number | Publication date |
---|---|
TW200842189A (en) | 2008-11-01 |
EP2011876A4 (en) | 2010-11-17 |
CN101495636A (zh) | 2009-07-29 |
CN101495636B (zh) | 2012-12-05 |
US8052977B2 (en) | 2011-11-08 |
EP2011876B1 (en) | 2014-11-12 |
WO2007119279A1 (ja) | 2007-10-25 |
EP2011876A1 (en) | 2009-01-07 |
US20090060951A1 (en) | 2009-03-05 |
JPWO2007119279A1 (ja) | 2009-08-27 |
IL194474A0 (en) | 2011-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5239023B2 (ja) | コイヘルペスウイルス(khv)病用dnaワクチン | |
EP2451827B1 (en) | Chimaeric protein | |
KR20210092762A (ko) | 아프리카 돼지 열병 바이러스에 대한 면역원성 조성물 | |
KR20170032441A (ko) | 코로나바이러스 | |
US20230124042A1 (en) | Vaccine against african swine fever virus infection | |
WO2022071513A1 (ja) | SARS-CoV-2に対する改良型DNAワクチン | |
US20210338807A1 (en) | Covid19 vaccines and related methods | |
WO2009082647A2 (en) | Recombinant rift valley fever (rvf) viruses and methods of use | |
WO2006002594A1 (fr) | Adenovirus canin de type 2 recombinant, procede d'elaboration et utilisation | |
TW202118771A (zh) | 疫苗 | |
WO2020089164A1 (en) | 4/91 ibv vaccine with heterologous spike protein | |
AU2020103776A4 (en) | Koi herpesvirus (khv) orf-149-based carbon nanotube supported nucleic acid vaccine and application thereof | |
KR20220038755A (ko) | 한타바이러스 항원성 조성물 | |
US20090162393A1 (en) | Vaccine composition and uses thereof | |
CN112159480B (zh) | 一种鸡传染性法氏囊病病毒多抗原表位蛋白及其应用 | |
TW201809273A (zh) | 病毒疫苗 | |
JP2019516745A (ja) | Hevワクチン | |
CN112370524A (zh) | 一种抗病毒组合物及其制备方法和应用 | |
JP6179903B2 (ja) | 海産魚の類結節症に対するdnaワクチン | |
US20030124567A1 (en) | Use of a leptospire protein preventing and/or diagnosing and/or treating animal or human leptospirosis | |
KR20030078807A (ko) | 양식 연어류 바이러스에 대한 복합 dna 및 단백질백신의 개발과 백신 처리 방법의 최적화 | |
WO2024003007A1 (en) | Recombinant spriviviruses, uses thereof and methods for producing the same | |
WO2023031869A1 (en) | Bovine ephemeral fever and lumpy skin disease antigenic constructs | |
KR20210010756A (ko) | 다가형 구제역 생백신 플랫폼 | |
TWI324160B (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100126 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120110 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120306 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120802 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120928 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130228 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |